Efficacy of Tacrolimus ointment in the treatment of tinea versicolor
Phase 2
- Conditions
- Pityriasis versicolor.Pityriasis versicolor
- Registration Number
- IRCT2014021216557N1
- Lead Sponsor
- Research Council of Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Clinical diagnosis of tinea versicolor; Confirmation of diagnosis by Wood's lamp examination (Yellow fluorescence) and Direct smear; Patients of 10 year old and over; Less than 15% of body surface area involvement
Exclusion criteria: Pregnancy or Lactation; History of hypersensitivity to main or preservative ingredients of topical tacrolimus or clotrimazole; Serious skin or systemic diseases; History of consumption of topical or systemic antifungal medications in the recent 1 month before enrolling in study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wood's lamp fluorescence. Timepoint: 0, 3rd, and 5th week. Method of measurement: Wood's lamp radiation.;Scale and hyperpigmentation grade. Timepoint: 0, 3rd, and 5th week. Method of measurement: Physician global assessment.;Malassezia species positivity. Timepoint: o, 3rd and 5th weeks. Method of measurement: Direct KOH 10% smear.
- Secondary Outcome Measures
Name Time Method Pruritus. Timepoint: 0, 3rd, and 5th week. Method of measurement: Visual assessment scale.;Hypopigmentation. Timepoint: 0, 3rd, and 5th week. Method of measurement: Physician global assessment.